Tandem Diabetes Care (TNDM) Net Income Growth (1y) (2014 - 2026)
Tandem Diabetes Care (TNDM) Net Income Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 99.11% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 89.28% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -30.10% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 125.69% |
| 10 | Tandem Diabetes Care | 1.17 Bn | 597.96 Mn | 136.79 Mn | 84.38% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 84.38% |
| Dec 31, 2025 | -171.92% |
| Sep 30, 2025 | 8.83% |
| Jun 30, 2025 | -70.12% |
| Mar 31, 2025 | -205.65% |
| Dec 31, 2024 | 102.52% |
| Sep 30, 2024 | 29.57% |
| Jun 30, 2024 | 13.80% |
| Mar 31, 2024 | 65.51% |
| Dec 31, 2023 | -88.58% |
| Sep 30, 2023 | 32.66% |
| Jun 30, 2023 | -137.51% |
| Mar 31, 2023 | -740.63% |
| Dec 31, 2022 | -247.63% |
| Sep 30, 2022 | -951.88% |
| Jun 30, 2022 | -476.25% |
| Mar 31, 2022 | -189.00% |
| Dec 31, 2021 | -36.75% |
| Sep 30, 2021 | 161.08% |
| Jun 30, 2021 | 113.69% |